Vinva Investment Management Ltd lessened its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 10.8% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 8,902 shares of the medical equipment provider’s stock after selling 1,080 shares during the quarter. Vinva Investment Management Ltd’s holdings in Intuitive Surgical were worth $4,691,000 at the end of the most recent quarter.
A number of other institutional investors have also recently made changes to their positions in the stock. VSM Wealth Advisory LLC purchased a new stake in Intuitive Surgical in the fourth quarter worth $67,000. Fox Hill Wealth Management purchased a new stake in Intuitive Surgical in the fourth quarter worth $2,636,000. Saiph Capital LLC lifted its stake in Intuitive Surgical by 17.2% in the fourth quarter. Saiph Capital LLC now owns 922 shares of the medical equipment provider’s stock worth $481,000 after acquiring an additional 135 shares during the period. OVERSEA CHINESE BANKING Corp Ltd purchased a new stake in Intuitive Surgical in the fourth quarter worth $283,000. Finally, Xponance Inc. lifted its stake in Intuitive Surgical by 2.5% in the fourth quarter. Xponance Inc. now owns 82,327 shares of the medical equipment provider’s stock worth $42,971,000 after acquiring an additional 1,982 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.
Analyst Upgrades and Downgrades
A number of brokerages recently commented on ISRG. Leerink Partners raised their price target on Intuitive Surgical from $490.00 to $548.00 in a research note on Monday, January 27th. Bernstein Bank raised their price target on Intuitive Surgical from $655.00 to $700.00 and gave the stock an “overweight” rating in a research note on Monday, January 27th. Truist Financial decreased their price objective on Intuitive Surgical from $666.00 to $605.00 and set a “buy” rating for the company in a report on Monday. Piper Sandler reiterated an “overweight” rating and issued a $670.00 price objective (up previously from $538.00) on shares of Intuitive Surgical in a report on Friday, January 24th. Finally, UBS Group increased their price objective on Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a report on Monday, January 27th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have given a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $611.86.
Intuitive Surgical Price Performance
Intuitive Surgical stock opened at $492.06 on Thursday. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The stock has a market capitalization of $175.26 billion, a PE ratio of 76.76, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43. The business’s fifty day moving average is $564.39 and its 200 day moving average is $531.62.
Insider Activity at Intuitive Surgical
In other Intuitive Surgical news, Director Amal M. Johnson sold 4,635 shares of the firm’s stock in a transaction dated Tuesday, January 28th. The stock was sold at an average price of $566.60, for a total value of $2,626,191.00. Following the transaction, the director now directly owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, EVP Robert Desantis sold 11,545 shares of the firm’s stock in a transaction dated Thursday, March 13th. The stock was sold at an average price of $499.22, for a total value of $5,763,494.90. Following the completion of the transaction, the executive vice president now directly owns 5,224 shares in the company, valued at $2,607,925.28. The trade was a 68.85 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 33,754 shares of company stock valued at $17,691,621 over the last ninety days. Insiders own 0.90% of the company’s stock.
Intuitive Surgical Company Profile
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
See Also
- Five stocks we like better than Intuitive Surgical
- The 3 Best Fintech Stocks to Buy Now
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- Consumer Staples Stocks, Explained
- Alphabet’s Officially In A Bear Market—Time To Buy?
- Following Congress Stock Trades
- D-Wave and Quantum Supremacy: Implications For Investors
Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.